HCPCS drug code · CMS crosswalk
Jylamvo J-Code / HCPCS Code
In short
Jylamvo is billed under HCPCS J8611 — Methotrexate (jylamvo), oral, 2.5 mg. One billing unit is 2.5 mg. CMS's crosswalk lists 1 Jylamvo NDC under this code.
Reference
- J8611
- Methotrexate (jylamvo), oral, 2.5 mgBilling unit: 2.5 mg
- Labelers
- Shorla Oncology Inc.
Medicare Part B payment limit
CMS ASP filePayment limit per unit$18.264
Per2.5 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Jylamvo units and claim line
Enter the dose given to get the J8611 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Jylamvo NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 81927-0204-01 | J8611 | Shorla Oncology Inc. | 60 | 48 |
Jylamvo: common questions
- What is the J-code for Jylamvo?
- Jylamvo is billed under HCPCS J8611 — Methotrexate (jylamvo), oral, 2.5 mg. One billing unit is 2.5 mg. CMS's crosswalk lists 1 Jylamvo NDC under this code.
- How many J8611 billing units are in a package of Jylamvo?
- CMS lists 48 billing units per package, depending on the NDC, where one unit is 2.5 mg. Units to report are based on the dose given, not the package.
- Is J8611 a CPT code?
- No. J8611 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.